dalbavancin, oritavancin and tedizolid are safe and effective for skin infection treatment

Dalbavancin, tedizolid phosphate, oritavancin diphosphate, and vedolizumab.

Antibacterial agents Skin and skin structure infections are most often caused by Grampositive bacteria such as streptococci and staphylococci. The number of these infections that are caused by methicillin-resistant Staphylococcus aureus (MRSA) has rapidly increased in recent years in both the community and hospital settings. MRSA skin infections experienced in the community can usually be effec...

Dalbavancin, Oritavancin, and Tedizolid for the Treatment of Skin and Soft Tissue Infections

Dalbavancin or oritavancin for skin infections.

To the Editor: Boucher et al. (June 5 issue)1 report the results of DISCOVER 1 and DISCOVER 2, and in the same issue Corey et al.2 report the results of SOLO I. These randomized trials investigated the efficacy of oritavancin and dalbavancin in acute bacterial skin and skin-structure infections. We are concerned that the design of these studies and that of other pivotal studies are not consiste...

Evaluation of Dalbavancin and Oritavancin as Cost-Effective Treatments of Acute Bacterial Skin and Skin Structure Infections in Hospitalized Patients

fluoride and dental fluorosis and treatment

چکیده ندارد.

New agents approved for treatment of acute staphylococcal skin infections

Vancomycin has been a predominant treatment for methicillin-resistant Staphylococcus aureus (MRSA) infections for decades. However, growing reservations about its efficacy led to an urgent need for new antibiotics effective against MRSA and other drug-resistant Staphylococcus aureus strains. This review covers three new anti-MRSA antibiotics that have been recently approved by the FDA: dalbavan...